Robert Bulloch, MD
Orthopaedic Surgery · Monroe, LANPI 1538145842
Payments from drug & device makers
Across 50 payments — averaging $104.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Midsouth Orthopedics Inc.$2K
- Arthrex$2K
- Stryker$217
- Curonix LLC$181
- Pacira Therapeutics, Inc.$91
- Johnson & Johnson$68
- plus $365 from 12 others
What the payments were for
- Travel & lodging$1,42327%
- Food & beverage$1,19523%
- Education$2,59950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Midsouth Orthopedics Inc. | 6 | $2,271 |
| Arthrex | 10 | $2,024 |
| Stryker | 4 | $217 |
| Curonix LLC | 1 | $181 |
| Pacira Therapeutics, Inc. | 4 | $91 |
| Johnson & Johnson(2 entities) | 3 | $68 |
| AbbVie | 3 | $57 |
| Endo Pharmaceuticals Inc. | 4 | $49 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Amgen | 2 | $34 |
| Vertex | 2 | $33 |
| Davol Inc. | 1 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Pfizer | 2 | $24 |
| Dynasplint Systems Inc. | 1 | $17 |
| Radius Health, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Bioventus LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,217 in reported general payments places this provider in the 55th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 133 | $882 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 98 | $770 |
| Celecoxib | 43 | $751 |
| Methocarbamol | 61 | $599 |
| Gabapentin | 72 | $534 |
| Tramadol Hcl | 68 | $193 |
| Tizanidine Hcl | 25 | $129 |
| Meloxicam | 19 | $93 |
| Cyclobenzaprine Hcl | 18 | $73 |
| Allopurinol | 17 | $63 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Monroe
- Sunny GuptaMonroe$40K
- William EnsmingerMonroe$28K
- Pierce NunleyShreveport$3.8M
- Christopher HarrodBaton Rouge$3.1M
- Vinod DasaKenner$1.9M
- Jorge IsazaBaton Rouge$1.2M
- Robert ZuraNew Orleans$792K
- Kevin McCarthyBaton Rouge$714K
- Fernando SanchezNew Orleans$655K
- Neil MakiThibodaux$620K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.